TL;DR
Intracardiac thrombus (ICT) is a rare but life-threatening complication of severe Mycoplasma pneumoniae pneumonia (SMPP) in children. This study reveals that these thrombi are typically "wall-attached" rather than mobile, suggesting they form in situ due to a massive inflammatory storm rather than traveling from elsewhere in the body.
What Problem Does This Paper Address?
Mycoplasma pneumoniae (MP) is a common cause of community-acquired pneumonia in children, but in severe cases (SMPP), it can trigger extrapulmonary complications. While myocarditis is well-documented, Intracardiac Thrombus (ICT)—a blood clot inside the heart—remains one of the rarest and most dangerous complications.
Because ICT is so rare, clinical data is sparse. Doctors often lack clear diagnostic markers or standardized treatment protocols. This paper seeks to fill that gap by identifying the clinical "red flags" (symptoms and lab markers) that distinguish SMPP patients who develop heart clots from those who don't, while also investigating the underlying pathophysiology of how these clots form.
Methods
The researchers employed a two-pronged approach:
- Retrospective Cohort Study: They analyzed 68 children with SMPP admitted to a major Chinese hospital between 2014 and 2024. They compared 18 patients who developed ICT against a control group of 50 patients who did not.
- Literature Review: To strengthen their findings, they synthesized data from 33 additional confirmed cases of SMPP-related ICT reported globally in 12 different studies.
Standard statistical tools (t-tests, $\chi^2$ tests, and binary logistic regression) were used to identify risk factors, while imaging (echocardiography and CTA) and histopathology provided a look at the thrombi themselves.
Datasets
The study utilizes a specialized clinical dataset:
- Primary Dataset: 68 pediatric patients from the Children’s Hospital Affiliated to Zhengzhou University.
- Secondary Dataset: A meta-analysis of 33 cases from literature spanning 2006 to 2024, including cases from China, India, Japan, France, Australia, and the USA.
- Total Sample Size: 51 ICT cases (the largest and most comprehensive investigation of this condition to date).
Key Insights and Ideas
- The "In Situ" Hypothesis: Unlike many cardiac clots that break off from elsewhere (emboli), these thrombi were almost exclusively attached to the heart wall or the chordae tendineae (the "heart strings"). This suggests the clots are growing directly on the endocardium, likely triggered by local inflammation and endocardial injury.
- The Inflammation Storm: The ICT group showed significantly higher levels of inflammatory markers (WBC, CRP, LDH, and Serum Ferritin). The authors propose that an "inflammation storm" induced by the infection is the primary driver of this pro-thrombotic state.
- Right Ventricle Predominance: In 68.6% of cases, the thrombus was located in the right ventricle. This is notable because it often co-occurred with pulmonary thrombosis (41.2%), suggesting a strong link between severe lung lesions and right-sided heart complications.
- Non-Specific Presentation: Interestingly, 33.3% of the ICT group had no thrombosis-specific symptoms, presenting only with standard pneumonia symptoms (fever and cough). This makes the complication incredibly easy to miss without proactive imaging.
Key Results
- Clinical Red Flags: Tachypnea (rapid breathing) and chest pain were significantly more common in the ICT group ($p < 0.001$).
- Laboratory Markers: D-dimer levels were significantly elevated in the ICT group (median 5.3 µg/mL vs 0.8 µg/mL in controls). However, the authors warn that 44.4% of ICT patients had D-dimer levels below 5 µg/mL, meaning a "normal" D-dimer does not entirely rule out a clot.
- Imaging: High-density lung consolidation involving $\ge 2/3$ of a lobe was a major indicator of ICT risk.
- Outcomes: Despite the severity, the prognosis was favorable with intervention. 94.4% of the study's ICT patients recovered. Treatment usually involved a combination of anticoagulation and, in 72.2% of their cases, surgical thrombectomy.
Limitations and Future Work
The authors acknowledge several limitations:
- Sample Size: Even with the literature review, 51 cases is a small sample for definitive clinical guidelines.
- Retrospective Design: The study relies on past records, which can introduce bias or missing data.
- Treatment Debate: There is still no consensus on when to choose surgery over conservative anticoagulation or thrombolysis.
- Future Directions: More research is needed to determine the exact "time window" for the most effective treatment and to clarify whether specific MP strains are more likely to cause these "inflammation storms."
Reference: Li, X., Zhai, B., Tang, Y. et al. Clinical features of intracardiac thrombotic complication in patients with severe Mycoplasma pneumoniae pneumonia. Ital J Pediatr 51, 42 (2025). https://doi.org/10.1186/s13052-025-01890-3
Summary updated